Ignite Creation Date:
2025-12-24 @ 7:32 PM
Ignite Modification Date:
2026-04-10 @ 2:08 AM
Study NCT ID:
NCT00529503
Status:
TERMINATED
Last Update Posted:
2015-02-25
First Post:
2007-09-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL
Sponsor:
Seagen Inc.
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Lymphoproliferative Disorders | View |
| None | Lymphoma | View |
| None | Antigens, CD40 | View |
| None | Antibody, Monoclonal | View |
| None | Combined Modality Therapy | View |
| None | Lymphoma, Large B-Cell, Diffuse | View |
| None | Lymphoma, Non-Hodgkin | View |
| None | Hematologic Diseases | View |
| None | Immunoproliferative Disorders | View |
| None | Lymphatic Diseases | View |